Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | XDH | P47989 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31473460 | 0.90 | KDM4E (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1759210 | 0.90 | KDM4E (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL25114613 | 0.89 | GAA (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8060962 | 0.89 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3717095 | 0.87 | CA1 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL20762798 | 0.87 | GAA (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL24901830 | 0.87 | GAA (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27214450 | 0.87 | CA1 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15358059 | 0.83 | NOTUM (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8336066 | 0.83 | CA1 (0.56) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101423-A1 | PHOTOSWITCHABLE CHEMICAL INDUCED DIMERIZATION SYSTEMS FOR CONTROL OF CELLULAR ACTIVITIES WITH LIGHT | WU YAOWEN (SE) | 2026-05-15 | — | — | WO | disclosed |
| EP-2826474-B1 | USE OF SUBSTITUTED DIPHENYLAMINE COMPOUNDS IN PREPARING ANTI-TUMOUR DRUGS | SINOCHEM CORP (CN) | 2021-05-26 | — | — | EP | disclosed |
| EP-3491922-A1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | Dow AgroSciences LLC (US) | 2019-06-05 | — | — | EP | disclosed |
| US-20180370905-A1 | Compounds Useful for the Treatment of Metabolic Disorders and Synthesis of the Same | NORTH CAROLINA CENTRAL UNIV (US) | 2018-12-27 | — | — | US | disclosed |
| CN-109071484-A | Molecule with desinsection effectiveness, and intermediate relevant to these molecules, composition and method | 美国陶氏益农公司 | 2018-12-21 | — | — | CN | disclosed |
| EP-3408262-A1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | Dow Agrosciences LLC (US) | 2018-12-05 | — | — | EP | disclosed |
| US-10005720-B2 | Compounds useful for the treatment of metabolic disorders and synthesis of the same | NORTH CAROLINA CENTRAL UNIVERSITY (US) | 2018-06-26 | — | — | US | disclosed |
| US-10005720-B2 | Compounds useful for the treatment of metabolic disorders and synthesis of the same | NORTH CAROLINA CENTRAL UNIVERSITY (US) | 2018-06-26 | — | — | US | disclosed |
| US-10005720-B2 | Compounds useful for the treatment of metabolic disorders and synthesis of the same | NORTH CAROLINA CENTRAL UNIVERSITY (US) | 2018-06-26 | — | — | US | disclosed |
| EP-2934142-B1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2018-01-31 | — | — | EP | disclosed |
| EP-0230532-B1 | 2-[(3,5-Dihalo-4-Aminobenzyl)] Imidazolines | ABBOTT LABORATORIES (US) | 1990-09-26 | — | — | EP | disclosed |
| EP-0294229-A2 | Novel heterocyclic pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-12-07 | — | — | EP | disclosed |
| EP-0279698-A2 | Pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-08-24 | — | — | EP | disclosed |
| EP-0230532-A1 | 2-[(3,5-Dihalo-4-Aminobenzyl)] Imidazolines | ABBOTT LABORATORIES (US) | 1987-08-05 | — | — | EP | disclosed |
| US-4665095-A | Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion | ABBOTT LABORATORIES (US) | 1987-05-12 | — | — | US | disclosed |
| EP-0107306-B1 | IMIDAZOLINE DERIVATIVES | BEECHAM GROUP PLC (GB) | 1986-04-30 | — | — | EP | disclosed |
| US-4505926-A | GASTROINTESTINAL DISORDERS ANTIDIARRHEA | BEECHAM GROUP P.L.C. (GB) | 1985-03-19 | — | — | US | disclosed |
| EP-0107306-A1 | Imidazoline derivatives | BEECHAM GROUP PLC (GB) | 1984-05-02 | — | — | EP | disclosed |
| US-4375478-A | ANTICHOLESTEROL AGENTS | ABBOTT LABORATORIES (US) | 1983-03-01 | — | — | US | disclosed |
| US-3960571-A | 1-PHENYL-2-PYRAZOL-5-ONE MAGENTA COLOR FORMING COUPLER | Fuji Photo Film Co., Ltd. (JA) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10005720-B2 | Compounds useful for the treatment of metabolic disorders and synthesis of the same | GLS2, PC, GLS | CA12 1478/4885CA1 1045/4885CA2 1038/4885 |
| US-20180370905-A1 | Compounds Useful for the Treatment of Metabolic Disorders and Synthesis of the Same | GLS2, PC, GLS | CA12 1478/4885CA1 1045/4885CA2 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.